Boston Scientific Stung by $3.4 Billion Charge
Medical device maker Boston Scientific (NYSE: BSX) has reported a second-quarter net loss of $3.40 billion, or $2.39 per diluted share. Adjusted earnings were $0.11 per share, which compares with $0.10 per share in…